Browsing by Author Zhang, Yuzi

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Showing results 1 to 6 of 6
Issue DateTitleAuthor(s)
Apr-2020Allele Frequency-Adjusted Blood-Based Tumor Mutational Burden as a Predictor of Overall Survival for Patients With NSCLC Treated With PD-(L)1 InhibitorsWang, Zhijie; Duan, Jianchun; Wang, Guoqiang; Zhao, Jing; Xu, Jiachen; Han, Jiefei; Zhao, Zhengyi; Zhao, Jun; Zhu, Bo; Zhuo, Minglei; Sun, Jianguo; Bai, Hua; Wan, Rui; Wang, Xin; Fei, Kailun; Wang, Shuhang; Zhao, Xiaochen; Zhang, Yuzi; Huang, Mengli; Huang, Depei; Qi, Chuang; Gao, Chan; Bai, Yuezong; Dong, Hua; Xiong, Lei; Tian, Yanhua; Wang, Di; Xu, Chunwei; Wang, Wenxian; Li, Junling; Hu, Xingsheng; Cai, Shangli; Wang, Jie
2019Assessment of Blood Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Patients With Non-Small Cell Lung Cancer With Use of a Next-Generation Sequencing Cancer Gene PanelWang, Zhijie; Duan, Jianchun; Cai, Shangli; Han, Miao; Dong, Hua; Zhao, Jun; Zhu, Bo; Wang, Shuhang; Zhuo, Minglei; Sun, Jianguo; Wang, Qiming; Bai, Hua; Han, Jiefei; Tian, Yanhua; Lu, Jing; Xu, Tongfu; Zhao, Xiaochen; Wang, Guoqiang; Cao, Xinkai; Li, Fugen; Wang, Dalei; Chen, Yuejun; Bai, Yuezong; Zhao, Jing; Zhao, Zhengyi; Zhang, Yuzi; Xiong, Lei; He, Jie; Gao, Shugeng; Wang, Jie
2019Comprehensive immune transcriptomic subtypes of colorectal cancer for development of precision immunotherapy.Jing, Zhou; Guo, Xueguang; Zhao, Jing; Zhao, Xiaochen; Zhang, Yuzi; Huang, Mengli; Cai, Shangli; Zhu, Haitao
20-May-2020Effect of MUC5B mutation on prognosis by enhancing the infiltration and antitumor immunity of cytotoxic T lymphocytes in the endometrial cancer.Zheng, Hong; Duan, Wei; Zhao, Qun; Li, Chengcheng; Wang, Guoqiang; Zhang, Yuzi; Bai, Yuezong; Zhou, Yingchun
2019Tumor mutation burden and immunogenicity in gastric cancer with HER2 alterations.Wei, Bo; Xing, Xiaojing; Li, Ziyu; Han, Quanli; Hao, Yingxue; Zhou, Jing; Zhang, Yuzi; Zhao, Jing; Cai, Shangli; Gu, Yanhong; Chen, Tufeng
Mar-2020Use of Immunotherapy With Programmed Cell Death 1 vs Programmed Cell Death Ligand 1 Inhibitors in Patients With Cancer A Systematic Review and Meta-analysisDuan, Jianchun; Cui, Longgang; Zhao, Xiaochen; Bai, Hua; Cai, Shangli; Wang, Guoqiang; Zhao, Zhengyi; Zhao, Jing; Chen, Shiqing; Song, Jia; Qi, Chuang; Wang, Qing; Huang, Mengli; Zhang, Yuzi; Huang, Depei; Bai, Yuezong; Sun, Feng; Lee, J. Jack; Wang, Zhijie; Wang, Jie